Navigation Links
Aspirin may help men with prostate cancer live longer, study suggests
Date:8/28/2012

DALLAS Aug. 28, 2012 Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, says a new study that includes a researcher at UT Southwestern Medical Center.

Taking aspirin is associated with a lower risk of death from prostate cancer, especially in men with high risk disease, according to a multicenter study published in today's issue of the Journal of Clinical Oncology. Dr. Kevin Choe, assistant professor of radiation oncology at UT Southwestern, is first author of the paper.

Preclinical studies have shown that aspirin and other anticoagulation medications may inhibit cancer growth and metastasis, but clinical data have been limited previously. The study looked at almost 6,000 men in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) database who had prostate cancer treated with surgery or radiotherapy.

About 2,200 of the men involved 37 percent were receiving anticoagulants (warfarin, clopidogrel, enoxaparin, and/or aspirin). The risk of death from prostate cancer was compared between those taking anticoagulants and those who were not.

The findings demonstrated that 10-year mortality from prostate cancer was significantly lower in the group taking anticoagulants, compared to the non-anticoagulant group 3 percent versus 8 percent, respectively. The risks of cancer recurrence and bone metastasis also were significantly lower. Further analysis suggested that this benefit was primarily derived from taking aspirin, as opposed to other types of anticoagulants.

The suggestion that aspirin, a frequently prescribed and relatively well-tolerated medication, may improve outcomes in prostate cancer is of particular interest, Dr. Choe said, since prostate cancer is the most common non-skin cancer among men and the second-leading cancer killer in the U.S.

'/>"/>

Contact: Alex Lyda
alex.lyda@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
2. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
3. Daily aspirin usage associated with lower cancer mortality
4. Study adds to evidence daily aspirin linked to lower cancer mortality
5. Aspirin protects against Barretts esophagus
6. Some Diabetics May Not Benefit From Daily Aspirin
7. Aspirin as Effective as Warfarin for Heart Failure: Study
8. Report says new evidence could tip the balance in aspirin cancer prevention care
9. Race May Affect Quality of Prostate Cancer Surgical Care
10. Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
11. Reducing the side effects of treatment for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... 2014 For many, fall turns daily life ... Ragweed is the most common cause of fall hay fever ... most common symptoms of ragweed allergy include a stuffed up ... allergy can also lead to wheezing, asthma attacks, and sinusitis. ... allergist about allergy immunotherapy - the only treatment shown to ...
(Date:8/31/2014)... order to celebrate the coming of autumn, Guangdong FODAY ... a big promotion. Now, all the global clients can access ... cars are made with great materials. FODAY Automobile strives to ... matter of fact, it is providing big discounts on many ... of cheap cars can visit its website for more details. ...
(Date:8/31/2014)... 2014 LabDoor.com tests the purity and ... According to their website, “We buy products in the ... stores and online sites. No manufacturer-supplied samples are permitted ... Healthy with LabDoor,” a recent study was performed on ... in the United States for Vitamin D3 content, heavy ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 In the ... of states have proposed legislation to require mandatory labeling ... can make informed purchasing decisions that affect their own ... industry leader advocating for stringent measures to eliminate GMOs ... its “Information, Communication, Engagement” (I.C.E.) initiative with the objective ...
(Date:8/31/2014)... 2014 Twin to twin transfusion syndrome (TTTS) ... Colp before they were born, but an innovative fetal surgery at ... the chance at life. , Now, their parents David and Theresa ... surgery option available in St. Louis at the St. Louis Fetal ... Market Pub House (6655 Delmar Blvd, St Louis, MO 63130) on ...
Breaking Medicine News(10 mins):Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 2Health News:AllergyEasy Announces Success Helping Patients Build Immunity To Autumn Ragweed Pollens With Under-the-tongue Drops 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 2Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 3Health News:#1 Rank Awarded to NutriGold’s Vitamin D3 Gold Supplement for the "Best Value" in Vitamin D 4Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 2Health News:NutriGold Announces its I.C.E. Initiative to Educate Consumers about GMOs in Dietary Supplements 3Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 2Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 3
... fasciitis, researchers say , , MONDAY, Dec. 1 (HealthDay ... fast, effective, non-invasive treatment for the painful foot ... combination of "dry-needling" and steroid injections guided by ... 95 percent success rate in tackling a condition ...
... NASHVILLE, Tenn., Dec. 1 Medication therapy management,(MTM) provider ... , New members ... Burcham; and Kevin Hutchinson. The three join an ... hone its MTM services, which work,to guard against medication ...
... take a close look at,the Part D drug coverage ... year. Medicare HMO and PPO plans in many ... deductibles with partial coverage,throughout the "gap" or "donut hole" ... $4,350 in out-of-pocket costs). HealthMetrix,Research Inc. screened over ...
... visit a dentist,in the mid-Michigan area, don,t be surprised if ... , Delta Dental of ... Care Association are spearheading a pilot,project designed to have dentists ... in patients. , "Dentists ...
... according to a large study performed at Leiden University ... study consisted of 1,331 patients who had suspected coronary ... artery segments were analyzed during the study. "We found ... stenosis in our patients; specificity was 91%," said Lucia ...
... shows for the first time how microscopic crystals form sound ... ends of cilia tiny cellular hairs in the ear ... important role in detecting sound, maintaining balance and regulating movement. ... for the most common form of vertigo. Known as benign ...
Cached Medicine News:Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:PharmMD Expands Advisory Board 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs 2Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 2Health News:Dental and Medical Communities Piloting Partnership in Mid-Michigan To Detect and Defeat Disease 3Health News:Can you hear me now? How the inner ear's sensors are made 2
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... CITY, Calif. , Aug. 29, 2014  Abaxis, ... company manufacturing point-of-care blood instrumentation and consumables to the ... Clint Severson , Chairman and Chief Executive Officer, will ... Best Ideas Conference 2014 on Tuesday, September 9, 2014 ... at the Omni Berkshire Place Hotel in ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... as We Age, Becomes Squarer, Makes You Look Older, ... Your face,may be giving away your age, and it ... eyelids. A study in January,s Plastic and,Reconstructive Surgery(R) (PRS), ... Surgeons (ASPS), found that as we age, the,lower jaw ...
... Colo. and MONTREAL, Jan. 9 Pharmion,Corporation ... (TSX: MYG) today announced,the enrollment of the ... trial (Trial,CL002) evaluating MGCD0103, the Companies, isotype-selective ... with,Vidaza(R) (azacitidine for injection), Pharmion,s DNA demethylating ...
Cached Medicine Technology:Looking Older? How Square is Your Jaw Line? 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
Medicine Products: